Les lentigines
نویسندگان
چکیده
منابع مشابه
[Topical tacrolimus-induced lentigines].
Varón de 11 años de raza caucásica y fototipo II con dermatitis atópica, que presenta desde hace 2 meses múltiples lesiones maculosas hiperpigmentadas de 1-2 mm de diámetro en huecos antecubitales (fig. 1). La dermatoscopia muestra retículo pigmentado delicado y zonas con glóbulos marrones (fig. 2). Durante los 8 meses previos a la consulta el paciente aplicó, sin realizar fotoprotección solar,...
متن کاملEruptive Lentigines after Adalimumab Therapy
Adalimumab, a TNF-alpha antagonist, is the first fully humanized recombinant immunoglobulin G1 (IgG1) monoclonal antibody. It is presently widely used in the systemic treatment of rheumatoid arthritis, inflammatory bowel disease, moderate and severe psoriasis and hidradenitis suppurativa. However, its administration is associated with a two-fold risk of severe and possibly fatal infections and ...
متن کاملEruptive acral lentigines--a new paraneoplastic sign?
Cutaneous signs may be the first indications of an internal disease. Any definitive sign of a neoplastic disease is of special importance since early diagnosis and early treatment may make a telling difference in improving prognosis. Presented is a 68-year-old patient with advanced stage melanoma that was associated with the appearance of multiple acral lentigines. The exact time-course of onse...
متن کاملAcral Lentigines, Is it a Paraneoplastic Syndrome?
We report a 34 years old gentleman who was referred to us with multiple brown spots on the palms, soles and scalp. He had those three months prior to being diagnosed with non-Hodgkin's lymphoma. His past history includes both Evan's syndrome and membranoproilferative glomerulonephritis treated by mycophenolate mofetil (MMF). On examination he had multiple brownish macules over the palms, soles ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pan African Medical Journal
سال: 2019
ISSN: 1937-8688
DOI: 10.11604/pamj.2019.33.190.15989